Prakash Nallathamby, associate director for research and assistant professor of the practice in the Berthiaume Institute for Precision Health, has assumed the role of co-navigator for the Indiana CTSI at Notre Dame as of November 1, 2023. He joins Jessica Brookshire, senior program director of community health and clinical partnerships, as the co-navigators for the program.

Prakash is replacing Paul Helquist, professor in the Department of Chemistry and Biochemistry, who is stepping down from his role as co-navigator at the end of the calendar year. 

We extend our immense gratitude to Paul, Jessica, and Prakash for their past and continued efforts for the Indiana CTSI and Notre Dame!

The Indiana CTSI has experts across a wide variety of fields and research areas of interest. Click the button below to have the latest research discoveries and developments making news and positively impacting health in Indiana delivered right to your inbox. 

Submission Deadline: November 20, 2023

The Indiana CTSI, jointly with the IU Kelley School of Business, is providing an opportunity to receive business management assistance by teams of Kelley School of Business students (2-5 students per project) for any IUSM CTSI-designated Cores, resources, programs and units that provide a central service to CTSI investigators (see RFA for examples of assistance).

Students are part of the IU Bloomington Kelley residential-MBA independent study program for course credit and the duration will be 8 weeks. Selected awardees will be expected to engage with the MBA students on the initial project scope (2 hours), additional follow-up or onsite meetings (8-12 hours) and a final project close-out (1-2 hours). Only IUSM CTSI-designated cores are eligible.

An article highlighting the contributions of previous Kelley MBA student teams to CTSI cores and resources was published on the Indiana CTSI website.

Selected projects will commence in early March 2024 and will be completed by early May 2024.

Contact: Rob Dimmitt, Sr. Director, Research Administration and Finance

Submission Deadline: January 11, 2024

The Indiana Clinical and Translational Sciences Institute is requesting applications for K12 Early Career Investigator clinical – translational research proposals.

These awards are designed to provide promising early career faculty investigators the opportunity to be mentored in research-intensive, multi-disciplinary settings toward the goal of developing careers in clinical - translational research. Emphasis of the Indiana CTSI K12 Early Career Investigator Awards in Clinical - Translational Research are to move findings from basic laboratory and pre-clinical research toward the development of new treatment options or interventions or clinical trials to eventual dissemination or clinical implementation to studying population health outcomes and health metrics. The phases of translational research may not necessarily be linear and can jump steps depending on the research project and the starting point. The goal of the Indiana CTSI is to make awards at all of these stages. It is important that the clinical - translational research have clear applications to human disease and health outcomes.

Interested applicants are strongly encouraged to send their current CV to Patricia McGuire for eligibility pre-screening no later than December 6, 2023.

Deadline for routing to ORA: January 9, 2024
Deadline for uploading ORA-Approved Proposal: January 16, 2024

Since 1975, IUSM has received research funding through gifts made possible from the Ralph W. and Grace M. Showalter Research Trust Fund. The areas of appropriate biomedical research, eligible for funding, are broad and described by the benefactors as “the type of medical research that is most likely to permanently benefit mankind.” Donor intent prohibits the use of Showalter Trust funds for research in psychiatry, sociology, or social studies.

Only current full-time faculty (non-visiting status) having a primary appointment in IUSM and a rank of assistant professor or assistant scientist are eligible to apply for funding from the Showalter Research Trust. Note that the same proposal may not be submitted as both a Biomedical Research Grant and a Showalter Trust application. If eligible for both programs, the investigator is encouraged to submit to the Showalter Trust.

Applications for funding from the Ralph W. and Grace M. Showalter Research Trust will be reviewed in two stages. An initial review by the IUSM Biomedical Research Committee (BRC) will select the most meritorious proposals for further discussion and ranking. The BRC will then provide a recommended ranking to the Showalter Trustees who conduct a second review. Final funding decisions are made by the Showalter Trustees.

Applications should have a maximum requested amount of $75,000.

Submission Deadline: January 16, 2024

The IUSM Research Enhancement Program is designed to stimulate research productivity at the statewide Centers for Medical Education (regional campuses) including the Bloomington Medical Sciences Program. This does not include the IUPUI campus. All full-time Center/Medical Sciences faculty, regardless of tenure status, having an appointment of Assistant/Associate/Full Professor or Assistant/Associate/Full Scientist at time of submission, are eligible to apply for a Research Enhancement Grant. Primary appointment must be in the School of Medicine. Faculty in visiting ranks are not eligible for funding through this mechanism.

Applications are considered small grants and should have a maximum requested amount of $50,000 and be limited to one (1) year duration

Contact: 317-278-2822, trnsldev@iu.edu

Extended Submission Deadline: January 31, 2024

The overarching goal of the Neurosciences Institute (NSI) Collaborative Pilot Grant is to provide pilot funding to support new research collaborations that will produce preliminary data needed to prepare subsequent research grant applications. Applications may include basic, translational, or clinical neuroscience researchers. Project must be responsive to the scientific mission of the NSI.

This initiative will provide $25,000, per year for a period of up to two years (total funding $50,000); second year of funding will be contingent on progress (as evaluated by the Pilot Grant Committee).

Contact: Lindsay Treadway

Letter of Intent Submission Deadline: Rolling submission
Full Submission Deadline: Rolling submission

IU Simon Comprehensive Cancer Center, Office of Community Outreach and Engagement is inviting collaborative proposals for implementing evidence-based cancer related programs within the community. Proposals should focus on the cancer burden in Indiana. The program should have an evaluation component and priority will be given to one of the major cancer burdens in Indiana including lung, breast, colon, pancreas, prostate and cervical. We are particularly interested in programs that can lower risk behaviors related to cancers which drive cancer incidence and morbidity. Of particular interest are community-led programs that will increase our reach or understanding of the underserved populations in Indiana. The project must be co-led by an IUSCCC faculty member and community advocate or partner.

The duration of this funding is one year, and the budget should not exceed $15,000.

Investigators wishing to apply to this funding mechanism must first submit a Letter of Intent for approval to Crystal Baker. Once approved, the link for submitting the online application will be sent.

Contact for Questions: Crystal Baker

Rolling Submission

The IU Simon Comprehensive Cancer Center (IUSCCC) is providing an opportunity to fund cancer focused PI-directed applications to the National Institutes of Health that have been reviewed once and missed the NIH pay line and have a high potential for obtaining external funding. The goal is to increase the cancer focused NIH funding base in the IUSCCC. Non-NCI targeted applications should have significant cancer relevance. This opportunity is limited to those who are IUSCCC members.

Investigators wishing to apply to this funding mechanism must first submit a draft cover letter (letter of intent) for approval by the IUSCCC Executive Committee before working with a Coordinator to submit a full application. Once approved, the link for submitting the online application will be sent.

Maximum allowable amount for R01, R42 and R44 grants is $50K with P01 and SPORE funding amounts evaluated on a case-by-case basis.

Contact for Letter of Intent and Questions: Kaitlin Condron or Crystal Baker

Want to learn more? You can view documents featuring ND-eligible funding opportunities as well as the other opportunities from the Indiana CTSI at these links.

If you have any questions about Indiana CTSI grants, programs, or upcoming events please feel free to reach out to co-navigators Jessica Brookshire, Paul Helquist, or Prakash Nallathamby.

The Indiana CTSI includes Indiana University, Purdue University, and the University of Notre Dame as the major academic partners along with a number of other institutions and entities in the state.

It is funded by a Clinical and Translational Sciences Award from the National Institutes of Health amounting to some $38 million for the current seven-year funding period of 2023-2030. This funding is supplemented by additional support from many other institutional and corporate partners.

Funding is provided to researchers by many mechanisms to promote translational and collaborative research among the partner institutions.

For more information, please visit: indianactsi.org